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Abstract
Background: The members of the protein kinase C (PKC) family consist of serine/threonine kinases classified
according to their regulatory domain. Those that belong to the novel PKC subfamily, such as PKCδ, are dependent
on diacylglycerol but not Calcium when considering their catalytic activity. Although several studies have shown
the importance of PKCδ in different cellular events in health and disease, the overall in vivo distribution of this PKC
isoform during development is still lacking. Through Lac Z and antibody staining procedures, we show here the
in vivo expression of PKCδ during mouse embryogenesis.
Results: Ganglia were the domains with most prominent expression of PKCδ in most of the stages analysed,
although PKCδ could also be detected in heart and somites at earlier stages, and cartilage primordium and skin
among other sites in older embryos.
Conclusions: The strong expression of PKCδ in ganglia during murine development shown in this study suggests a
significant role of this isoform as well as redundancy with other PKCs within the nervous system, since PKCδ
deficient mice develop normally.
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Background
In mammals, the PKC family consists of at least 10 serine/
threonine kinases grouped into three subfamilies attending
to their regulatory domain and requirements for their acti-
vation. Unlike conventional PKCs, novel PKCs (nPKC),
such as PKCδ, are not dependent on calcium but on dia-
cylglycerol to change from their self-inhibited state to their
active conformation [1]. PKCδ activity can be regulated in
different manners, including phosphorylation of its activa-
tion loop by kinases [2] and by autophosphorylation of dif-
ferent sites throughout its regulatory domain and hinge
region [3]. In addition, it can become a lipid-independent
enzyme with altered substrate specificity under certain
conditions [3] and show altered cofactor requirements [4].
PKCδ interacts with different proteins, such as Shc [5] or
p23 [6], and in its active state is able to phosphorylate dif-
ferent substrates, such as STATs [7] or ERK [8]. Function-
ally, PKCδ regulates different processes, such as cell cycle
(by either slowing [9,10] or promoting [8,11] cell prolifera-
tion, depending on the context), apoptosis [12], cell
migration [13] or transcription [14]. Also, although PKCδ
deficiency does not prevent mouse viability [15], this iso-
form appears important in different contexts in health, as
in the immune system [16] or insulin sensitivity [17], and
disease, as for example in arteriosclerosis [15]. However,
data regarding the general PKCδ expression pattern during
mouse embryogenesis are still missing. This study shows
the spatiotemporal expression of PKCδ during midgesta-
tion by immunostaining wild type mouse embryo sections
and by using PKCδ deficient embryos expressing the LacZ
reporter gene under the control of the endogenous PKCδ
promoter. These results could be helpful when addressing
functional redundancy or exclusiveness of this nPKC dur-
ing murine development.
Results and discussion
PKCδ expression from E8.5 to E9.5
PKCδ analysis was mainly performed through LacZ
staining. Antibody staining with the corresponding nega-
tive controls was also performed at E9.5 and E13.5 to-
gether with the LacZ staining method as a control for
the specifity of the LacZ signal. To confirm the absence
of endogenous β-galactosidase activity in our stainings,
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wild type littermates underwent the same protocol in
parallel (Figures 1A-C).
At E8.5, whole mount LacZ staining showed signal
mainly at the primitive heart and yolk sac (Figure 1C).
Whole mount LacZ staining of PKCδ deficient embryos
at E9.5 showed signal in rostral extremity of the noto-
chord, trigeminal (V) neural crest tissue, dorsal aorta,
pericardium, and developing heart. A closer look to the
heart allowed for visualization of walls of the primitive
ventricle, atrium and truncus arteriosus (Figures 1E-H).
Immunostaining of wild type embryo sections at E9.5 con-
firmed expression of PKCδ in somites and the same areas
of the heart and pericardium (Figures 1I-L). The specifi-
city of the signal given by the antibody was confirmed by
using PKCδ deficient embryo sections corresponding to
the same developmental stage (Figure 1J).
PKCδ expression from E10.5 to E12.5
At E10.5, novel β-galactosidase activity was observed at
the roof of the hind brain, third branchial pouch, fourth
branchial pouch and mandibular component of the first
branchial arch (Figures 2A and B). The signal observed
at E9.5 in trigeminal (V) neural crest tissue became
more prominent at E10.5 (Figures 2A and B). E11.5 was
the earliest developmental stage at which ganglia started
to show Lac Z reporter signal. Thus, dorsal root ganglia,
facio-acoustic (VII-VIII) ganglion complex and trigem-
inal (V) ganglia all displayed β-galactosidase activity
(Figure 2C). In 12.5 dpc embryos, dorsal root ganglia
showed increased LacZ staining, and the trigeminal (V)
ganglion became also prominently stained (Figures 2D
and E). In addition, novel signal was detected at this
stage in the vestibulocochlear ganglion (Figure 2D) and
Figure 1 PKCδ expression at E8.5 and E9.5. A-C, lack of signal due to endogenous β-galactosidase was confirmed by applying the same LacZ
staining protocols on wild type embryos (controls). D, at E8.5, X-Gal staining is detected in the yolk sac and primitive heart (ys and ph,
respectively). E-H, at E9.5, trigeminal (V) neural crest tissue (tnc), rostral extremity of the notochord (not), dorsal aorta (dor), somites (som),
pericardium (per) and developing heart all showed LacZ signal. In the latter, reporter activity was detected at the walls of the primitive ventricle
(ven), atrium (atr) and truncus arteriosus (tru). I-L, Antibody staining of 4 μm E.9.5 embryo sections confirmed the expression of PKCδ in heart and
somites. E9.5 PKCδ deficient embryo sections (J) were used as a negative control for the antibody.
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neural tube (Figure 2E). The broad and strong LacZ re-
porter activity detected in ganglia suggests that PKCδ
may have a significant role within the nervous system in
mice. However, there is no obvious defect within the
nervous system during murine development and adult-
hood. We believe this is due to functional redundancy
among members of the PKC family. For example, over-
lapping expression of PKC δ [18] and ε [19] within the
nervous system can be already found as part of a recent
study that uses an in situ hybridization approach to
show the expression pattern of a high number of tran-
scripts in the mouse embryo [20]. Thus, a redundancy
where these two isoforms compensate each other could
be a reason why no obvious phenotype is observed in
the nervous system of PKC δ or ε single deficient mice
during mouse embryogenesis.
At 12.5 dpc, embryos also showed novel reporter
activity at the precartilage primordia of bone at
forelimbs and hindlimbs, such as femur and radius
(Figures 2F and G).
PKCδ expression at embryonic stages E13.5 and E14.5
At E13.5 (Figure 3), dorsal root ganglia showed approxi-
mately the same strong LacZ signal observed in trigem-
inal (V) ganglia (Figures 3A-D). New domains with
β-galactosidase activity at this stage of development were
the caudal part of the medulla oblongata, inferior gan-
glion of glossofaringeal (XI) nerve, skin, and choroid
plexus (Figures 3A-D). However, LacZ signal in the
latter two domains was not detectable in PKCδ+/−
embryos (Figure 2B). At this stage, LacZ-stained
embryos were also embedded in paraffin blocks to gen-
erate sections that could let us better identify domains
where β-galactosidase activity occurred. Given the low
signal observed in the 4 μm-thick sections, 15 μm sec-
tions were used instead in order to obtain a more prom-
inent LacZ staining signal. Unfortunately, sections of
such thickness affected somewhat the quality of the cor-
responding photographs. However, we were still able to
identify domains that could also be observed in whole
mount embryos, such as dorsal root ganglia, trigeminal
(V) ganglion, vestibulocochlear ganglion, neural tube or
cartilage primordium at limbs (Figures 3E-K), as well as
new areas that we could not see in whole embryos, such
as loop of midgut within physiological umbilical hernia,
dorsal part of tongue and lower border of nasal septum
(Figures 3L-M). At this stage, there seemed to be pro-
blems with penetration of X-Gal in the embryo and
therefore proper detection of signal in several domains,
such as trigeminal ganglion (Figure 3G). Furthermore,
sites such as stomach, which appeared stained at E12.5
(data not shown), was not detectable at E13.5, possibly
due to the same problem. We also performed immunos-
taining of PKCδ in wild type and PKCδ deficient (nega-
tive control) mouse embryo sections at E13.5, which
confirmed its expression at sites already identified in
Figure 2 PKCδ expression in whole mount embryos from E10.5 to E12.5. A and B, at E10.5, roof of the hindbrain (rhb), third branchial
pouch (tbp), fourth branchial pouch (fbp) and mandibular component of the first branchial arch show novel LacZ reporter activity. Signal at the
trigeminal (V) neural crest tissue (tnc) became more prominent than at E9.5. Figure B is a close-up of the inset found in fig. A. C, At stage E11.5,
staining of the trigeminal (V) ganglion (trg), facio-acoustic (VII-VIII) ganglion complex (fag), and dorsal root ganglia (drg) appeared all LacZ stained.
D-G, 12.5 dpc embryos show increased signal in dorsal root ganglia (drg), strong LacZ activity in the trigeminal ganglion (trg), and novel activity
at vestibulocochlear ganglion (ves), neural tube (neu) and precartilage primordia of bones at forelimbs (for) and hindlimbs (hin).
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LacZ stained embryos: dorsal root ganglia, inferior gan-
glion of glossofaringeal (XI) nerve, vestibulocochlear
ganglion, trigeminal (V) ganglion, loop of midgut within
physiological umbilical hernia dorsal part of tongue,
lower border of nasal septum, and cartilage primordium
at limbs (Figures 3N-W). In addition, antibodies to
PKCδ applied on cross sections also revealed expression
in the stomach and metanephros (Figure 3X). Sagittal
sections reported the atrium of the heart, which could
not be seen in LacZ stained embryos or sections,
Figure 3 (See legend on next page.)
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possibly due to penetration issues of X-Gal (Figure 4Y),
as earlier mentioned. There were some areas detected
through Lac Z staining that could not be detected via
immunostaining. In these areas, the Neo cassette that
was used to generate PKCδ deficient mice might have
influenced the expression of PKCδ [21], although PKCδ
might instead be too lowly expressed to see immuno-
signal with the protocol we used.
Consistent with previous mRNA studies at E14.5 [20],
our LacZ staining of embryos at this stage showed signal
in brain, neural tube and ganglia (Figures 4A and B).
However, we also found β-galactosidase activity at sites
that we already described at earlier stages in this study,
but whose patterns have not been reported before in
such work at the mRNA, such as skin (Figure 4A, which
also appeared LacZ stained in heterozygous embryos,
unlike at E13.5) or cartilage primordia of bones (mainly
at limbs, Figure 4C). The staining in bone was more
prominent and more defined than when identified at
E12.5. Here, it could be readily observed in precartilage
primordia of digit, precartilage primordial of phalangeal
bone, and metatarsal bone (Figure 4C). In addition, 14.5
dpc embryos displayed LacZ rerporter activity at whis-
kers and precartilage primordium of nasal septum
(Figure 4D).
Conclusions
Our expression pattern for PKCδ during mouse midges-
tation suggests that several domains, such as cartilage
primordium or skin, express this novel PKC isoform.
However, the nervous system is the main site of expres-
sion for PKCδ. More specifically, dorsal root ganglia and
trigeminal (V) ganglia are the domains where PKCδ
seems to be most prominently expressed. Thus, these
data suggest that PKCδ may have an important role
within the nervous system in mice, as already suggested
by studies in other species [22,23]. The fact that there is
no reported phenotype or functional deficiency in the
nervous system suggest the existence of functional re-
dundancy among members of the PKC family. Thus, the
expression pattern of PKCδ may contribute to address
such redundancy in function as well as to identify
domains causing potential lethality in mice lacking sev-
eral PKC isoforms.
Methods
Animals and embryo collection
Generation of mice (129/SvPasCrl) carrying the mutated
allele for PKCδ has been previously described [15]. All ani-
mal work was approved by the Folkehelse Institute, Oslo
(Norway) and performed according to its institutional
(See figure on previous page.)
Figure 3 PKCδ expression is highest within the nervous system at E13.5. A-D, at embryonic stage E13.5, whole mount staining allowed for
the detection of LacZ signal in skin (ski) in homozygous but not heterozygous embryos. Choroid plexus (cho), neural tube (neu), caudal region of
the medulla oblongata (cmo), inferior ganglion of glossofaringeal (XI) nerve (inf), trigeminal (V) ganglion (trg), and dorsal root ganglia (drg) all
showed novel β-galactosidase activity in whole embryos. E-M, 15 μm sagittal sections were obtained from LacZ stained embryos. Reporter
activity observed in most cells of dorsal root ganglia (drg), trigeminal (V) ganglion (trg), inferior ganglion of glossofaringeal (XI) nerve (inf),
vestibulocochlear ganglion (ves) and neural tube confirmed the signal observed in LacZ-stained whole embryos. Also, LacZ reporter activity was
detected at cartilage primordium at limbs (pre), the loop of midgut within physiological umbilical hernia (loo), dorsal part of tongue (ton), and
lower border of nasal septum (sep). Areas labelled as * could be detected only via LacZ staining and thus were not reported. N and O, at E13.5,
PKCδ deficient mouse sections (δ−/−) were used as negative controls for immunohistochestristry (A and B). P-Y, at E13.5, antibodies to PKCδ
confirmed LacZ staining at dorsal root ganglia (drg), trigeminal (V) ganglion (trg), inferior ganglion of glossofaringeal (XI) nerve (inf),
vestibulocochlear ganglion (ves), loop of midgut within physiological umbilical hernia (loo), dorsal part of tongue (ton) and lower border of nasal
septum (sep). Cross sections allowed for immunodetection of PKCδ in cartilage primordium at limbs (pre), metanephros (met) and wall and
mucosal lining of the stomach (sto). In addition, antibody staining was detected in the atrium of the heart (atr).
Figure 4 PKCδ expression at E14.5. A-D, in 14.5 dpc embryos, increased LacZ activity was detected in choroid plexus (cho), caudal part of
medula oblongata (cmo), skin (ski), dorsal root ganglia (drg) and neural tube (neu). More defined signal than at previous stages was also found in
precartilage primordia of digit (dig), precartilage primordial of phalangeal bone (pha) and metatarsal bone (met). LacZ reporter activity was also
observed in whiskers (whi) and precartilage primordium of nasal septum (nas).
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guidelines and to the rules and regulations of the Fe-
deration of European Laboratory Animal Science Associ-
ation´s (FELASA). Pregnancy stages were assigned upon
observation of vaginal plug at approximately midday,
which was considered as E0.5.
LacZ staining
Steps corresponding to fixation (4% paraformaldedyde in
PBS) and washing/permeabilization (Na2HPO4 85 mM,
NaH2PO4 16mM, MgCl2 2mM, 0.01% Na-desoxycholate,
0.02% NP-40) were performed for either 5 min (embryos
up to 9.5 dpc) or 15 min (embryos from 10.5 dpc) at room
temperature. Upon isolation, embryos were fixed, washed
three times, and incubated with gentle shaking and pro-
tected from light overnight at 37°C in staining solution
(for 10 ml, 9.7 ml of washing solution, 200 μl of K3[Fe
(CN)6] 0.5 M, 200 μl of K4[Fe(CN)6] 0.5 M, and 175 μl of
50 mg/ml X-Gal (Sigma-Aldrich) in DMSO were used).
Next day, embryos were washed three times at room
temperature and postfixed in 4% formalin in washing so-
lution overnight at +4ªC. PKCδ −/− embryos (unless
otherwise stated) were then passed into increasing con-
centrations of glycerol (25%, 50% and 80%) and photo-
graphed by using a Zeiss stereoscope equipped with
camera and Axiovision software. LacZ stained embryos to
be sectioned were instead postfixed in bouin’s solution
(Sigma) the next day after β-gal staining, washed 3 times
in PBS, passed into increasing concentrations of ethanol
(30%, 50%, 70% and 100%, 2 washes per concentration),
placed into a mix 1:1 of Ethanol-xylene, washed 2 times in
xylene, and finally embedded in paraffin.
Immunostaining
Paraffin embedded sections of 9.5 and 13.5 dpc embryos
were dewaxed using the following routine: 2 washes in
xylol for 10 min, 2 washes in absolute ethanol for 5 min,
1 wash in 70% ethanol for 2 min, and at least 5 min in
distilled water. Sections were then boiled for two min-
utes in citric acid pH 6.0 for antigen retrieval, washed
three times in PBS, bleached for 20 min with a mix of
30% peroxide, 1M HCl, and methanol with the ratio
1:1:100, respectively, and incubated overnight in rabbit
polyclonal anti mouse PKCδ (C-17, Santa Cruz Biotech-
nology) in a 1:200 dilution in PBS containing 5% fetal
calf serum (FCS). Next day, sections were washed in PBS
and incubated for two hours at room temperature in
goat antirabbit IgGs conjugated to horse radish peroxid-
ase (HRP, Jackson Immunoresearch) in a 1:200 dilution
in PBS containing 5% FCS. Detection of PKC δ was then
analyzed using the DBA method according to the manu-
facturer’s instructions (Biogenex).
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